CD44 and breast cancer: A large population of CD44+/CD24− cells (80.3 and 56.7%, respectively) was characteristic for highly metastatic Bb-subtype BC cells (median value=72.1%) including MDA-MB-231 or Hs578T (Hughes et al, 2008).